We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
athenahealth (ATHN): Beats on Q3 Earnings, Inks Partnership
Read MoreHide Full Article
athenahealth reported adjusted earnings of 35 cents per share, much better than 11 cents recorded in the year-ago quarter. Earnings also crushed the Zacks Consensus Estimate by a notable 14 cents, courtesy of a year-over-year rise in revenues.
Meanwhile, athenahealth announced a strategic partnership with Tandigm Health. Notably, Tandigm has selected athenhealth’s Population Health platform for its primary care physician base of 440.
The Watertown-Massachusetts based maker of billing and medical practice management software posted revenues of $276.6 million, which missed the Zacks Consensus Estimate of $280 million but increased 16.6% on a year-over-year basis.
Notably, shares dropped approximately 2% to $119.45 following the earnings release. A glimpse at the share price trend reveals lackluster market sentiments as athenhealth represents a negative one-year return of almost 6.8% which compares unfavorably with the S&P 500’s 4.3% over the same time frame.
The launch of AthenaInsight was of main attraction in the third quarter. Notably, athenalnsight is a daily news hub which keeps track of the activities of healthcare providers and ‘de-identified patients’ of the nation. The platform exclusively offers comprehensive information pertaining to the healthcare industry.
Segment Details
athenahealth reported Business and Services revenues of $267.1 million, up 18.7% from the year-ago quarter. However, implementation and other segment posted revenues of $9.5 million were down 13.8% from the same quarter last year.
A strong client base has been a major growth driver for the company. Applications like athenaClinicals, athenaClinicals-Streamlined, athenaInsight, athenaCommunicator, athenaOne, athenaCollector for Hospital and Health Systems and the brand promise of ‘Unbreak Healthcare’ are fortifying the company’s market position in terms of exclusiveness of services provided in the respective markets.
athenahealth’s huge client base and solid network expansion are major positives. Notably, the company registered 3,829 new active physicians in athenaCollector, 2,090 physicians in athenaClinicals and 3,416 physicians in athenaCommunicator in the quarter, compared with 3,953 physicians in athenaCollector, 2,818 physicians in athenaClinicals and 3,422 physicians in athenaCommunicator in the same quarter last year.
Margin Details
Adjusted gross margin was 65.0%, compared with 62.9% in the year-earlier quarter.
Operating expenses, as a percentage of revenues, surged a notable 410 basis points (bps). The increase is primarily attributable to the 40 bps and 120 bps respective increases in general and administrative costs and expenses on depreciation and amortization (as percentage of revenues). Operating margin also increased 410 bps on a year-over-year basis to 5.5%.
However, selling & marketing and research and development (R&D) expenses, as a percentage of revenues, decreased 230 bps and 60 bps respectively on a year-over-year basis.
Guidance
For 2016, athenahealth maintains total revenue projection at the range of $1.085–$1.115 billion. Adjusted earnings are estimated in the $1.65–$1.85 per share band.
The adjusted operating income is expected between $120 million and $135 million while adjusted gross margin is projected in the band of 63.5%--64.5%. The adjusted tax rate is expected to be around 40%.
Key Picks
Currently athenahealth carries a Zacks Rank #3 (Hold).
ABIOMED has a long-term expected earnings growth rate of approximately 26.7%. Notably, the stock represents an impressive one-year return of 42.7%.
AngioDynamics has a long-term expected earnings growth rate of 15.00%. The company posted a solid one-year return of almost 45%.
Glaukos Corporation recorded a stellar one-year return of almost 63%. Notably, the company posted positive surprises in the past four quarters, the average being 110.9%.
Confidential from Zacks
Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
athenahealth (ATHN): Beats on Q3 Earnings, Inks Partnership
athenahealth reported adjusted earnings of 35 cents per share, much better than 11 cents recorded in the year-ago quarter. Earnings also crushed the Zacks Consensus Estimate by a notable 14 cents, courtesy of a year-over-year rise in revenues.
Meanwhile, athenahealth announced a strategic partnership with Tandigm Health. Notably, Tandigm has selected athenhealth’s Population Health platform for its primary care physician base of 440.
The Watertown-Massachusetts based maker of billing and medical practice management software posted revenues of $276.6 million, which missed the Zacks Consensus Estimate of $280 million but increased 16.6% on a year-over-year basis.
Notably, shares dropped approximately 2% to $119.45 following the earnings release. A glimpse at the share price trend reveals lackluster market sentiments as athenhealth represents a negative one-year return of almost 6.8% which compares unfavorably with the S&P 500’s 4.3% over the same time frame.
Quarter Highlights
The launch of AthenaInsight was of main attraction in the third quarter. Notably, athenalnsight is a daily news hub which keeps track of the activities of healthcare providers and ‘de-identified patients’ of the nation. The platform exclusively offers comprehensive information pertaining to the healthcare industry.
Segment Details
athenahealth reported Business and Services revenues of $267.1 million, up 18.7% from the year-ago quarter. However, implementation and other segment posted revenues of $9.5 million were down 13.8% from the same quarter last year.
A strong client base has been a major growth driver for the company. Applications like athenaClinicals, athenaClinicals-Streamlined, athenaInsight, athenaCommunicator, athenaOne, athenaCollector for Hospital and Health Systems and the brand promise of ‘Unbreak Healthcare’ are fortifying the company’s market position in terms of exclusiveness of services provided in the respective markets.
ATHENAHEALTH IN Price, Consensus and EPS Surprise
ATHENAHEALTH IN Price, Consensus and EPS Surprise | ATHENAHEALTH IN Quote
Physician Details
athenahealth’s huge client base and solid network expansion are major positives. Notably, the company registered 3,829 new active physicians in athenaCollector, 2,090 physicians in athenaClinicals and 3,416 physicians in athenaCommunicator in the quarter, compared with 3,953 physicians in athenaCollector, 2,818 physicians in athenaClinicals and 3,422 physicians in athenaCommunicator in the same quarter last year.
Margin Details
Adjusted gross margin was 65.0%, compared with 62.9% in the year-earlier quarter.
Operating expenses, as a percentage of revenues, surged a notable 410 basis points (bps). The increase is primarily attributable to the 40 bps and 120 bps respective increases in general and administrative costs and expenses on depreciation and amortization (as percentage of revenues). Operating margin also increased 410 bps on a year-over-year basis to 5.5%.
However, selling & marketing and research and development (R&D) expenses, as a percentage of revenues, decreased 230 bps and 60 bps respectively on a year-over-year basis.
Guidance
For 2016, athenahealth maintains total revenue projection at the range of $1.085–$1.115 billion. Adjusted earnings are estimated in the $1.65–$1.85 per share band.
The adjusted operating income is expected between $120 million and $135 million while adjusted gross margin is projected in the band of 63.5%--64.5%. The adjusted tax rate is expected to be around 40%.
Key Picks
Currently athenahealth carries a Zacks Rank #3 (Hold).
Better-ranked stocks in the broader medical sector are ABIOMED Inc. , AngioDynamics Inc. (ANGO - Free Report) and Glaukos Corporation (GKOS - Free Report) . Notably, all the companies sport a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
ABIOMED has a long-term expected earnings growth rate of approximately 26.7%. Notably, the stock represents an impressive one-year return of 42.7%.
AngioDynamics has a long-term expected earnings growth rate of 15.00%. The company posted a solid one-year return of almost 45%.
Glaukos Corporation recorded a stellar one-year return of almost 63%. Notably, the company posted positive surprises in the past four quarters, the average being 110.9%.
Confidential from Zacks
Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>